MIB Agents OsteoBites and osTEAo

Por: MIB Agents Osteosarcoma
Each week, MIB Agents talks with the leaders and innovators in osteosarcoma surgery, research, treatment and advocacy. Questions are taken during the webinar and are included in each podcast. More information is available at www.mibagents.org
201 episodios disponibles

Latest episodes of the podcast MIB Agents OsteoBites and osTEAo

Mostrando página 3 de 11

The ablative and immunomodulatory effects of histotripsy treatment in osteosarcoma 25/10/2024
osTEAo: Spooky Sarcoma Stories 17/10/2024
Molecular and cellular deconstruction of metastatic osteosarcoma 27/09/2024
osTEAo: Back to School: Cancer + Curriculum 18/09/2024
Fit for Filing Academic Clinical Trials: An Industry Perspective 30/08/2024
Magnetic Resonance Guided (MRg) High Intensity Focused Ultrasound (HIFU) For Palliation of Canine Appendicular Osteosarcoma 23/08/2024
osTEAo - Clear Scans…So Now What? 15/08/2024
Clinical Utility of Functional Precision Medicine to Guide Treatments for Osteosarcoma Patients 08/08/2024
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy 02/08/2024
A Multi-Institution Study in Combination with Relapsed or Refractory Pediatric Bone and Soft Tissue 26/07/2024
osTEAo: The Sibling Situation 17/07/2024
Genomes, Avatars and AI: The Future of Personalized Medicine 11/07/2024
Exploring Novel Immunotherapies for Canine Osteosarcoma 31/05/2024
A Guide to the FACTOR 2024 Scientific Panels with Matteo Trucco, MD 24/05/2024
osTEAo: Long Term Side Effects from Treatment For Osteosarcoma and AYA Cancer 15/05/2024
Creating a translational genomic framework for canine osteosarcoma: updates on the NCI DOG2 project 10/05/2024
Positioning Poly-(ADP)-ribose polymerase inhibitors (PARPi) for the treatment of Osteosarcoma 03/05/2024
TGF-beta inhibition as a novel therapeutic option in Osteosarcoma 25/04/2024
Out on a Limb - Travel Tips for AYA Cancer Patients 17/04/2024
Phase 1 Study of Cabozantinib in Combination with Topotecan-Cyclophosphamide for Patients with Relapsed or Refractory Ewing Sarcoma or Osteosarcoma 11/04/2024
« Primera ‹ Anterior 1 2 3 4 5 ... 11 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA